The Patent Finder

PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors

Forma Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application 62/692,591, filed Jun 29, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,834,539PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · High confidence
Forma Therapeutics, Inc.In force
High confidence
US 10,414,752PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · Low confidence
Forma Therapeutics, Inc.In force
Low confidence
US 10,550,098PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · Low confidence
Forma Therapeutics, Inc.In force
Low confidence
US 10,889,567PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · Low confidence
Forma Therapeutics, Inc.In force
Low confidence
US 11,498,913PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · Low confidence
Forma Therapeutics, Inc.In force
Low confidence
US 12,275,715PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
In force
 · Low confidence
Forma Therapeutics, Inc.In force
Low confidence
US 10,532,047Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile
In force
 · High confidence
Forma Therapeutics, Inc.In force
High confidence
US 10,959,994Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile
In force
 · High confidence
Forma Therapeutics, Inc.In force
High confidence
US 11,013,733Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1)
In force
 · High confidence
Forma Therapeutics, Inc.In force
High confidence
US 11,013,734Treating Patients Harboring an Isocitrate DEHYDROGENASE-1 (IDH-1) Mutation
In force
 · High confidence
Forma Therapeutics, Inc.In force
High confidence
19 more patents in this group · Pro
10 of 29 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 29.
Upgrade to Pro
18 of these are in force and held by Forma Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited